No contraindication exists for concurrent use with anticoagulants including warfarin, DOACs (apixaban, rivaroxaban, edoxaban, dabigatran), or low-molecular-weight heparins
However, the Cleveland Clinic Journal of Medicine 30 positions that the benefits of GLP-1 medications outweigh the risks and until more is known, there's little reason to withhold use unless coming from a personal or family history of medullary or follicular thyroid cancers
It plays a key role in regulating blood sugar, promoting fullness, and supporting insulin release
Also, the inclusion of the drugs in public drug formularies and expanded insurance coverage for chronic condition management escalates accessibility, especially for underserved populations, and is driving the demand and growth of the market
Researchers commonly use it in studies of weight loss and metabolic peptides
For patients taking warfarin, more frequent INR monitoring is recommended during semaglutide initiation or dose changes, as a prudent clinical practice